Ginkgo Bioworks Reports First Quarter 2022 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/19/2026
- Wall St rises as yields ease, Moderna lifts healthcare stocks
- U.S. Treasury doubles buyback operation size for long-dated bonds
- Marvell shares jump after giving Google warrants amid custom chip deal
- U.S. debt tops $40 trillion
- Nvidia credit risk gauge hits new peak as SoftBank readies record bond issue
- Marvell issues Google warrant tied to custom chip deal
- Tech selloff weighs down Wall Street as bond yields climb
- FOMC minutes from July 28-29th meeting
- Lowe's Cos. (LOW) Tops Q2 EPS by 17c, Misses on Revenue; Offers Fy27 Guidance
- Nvidia or Sandisk? BofA reveals which stock is under-owned and which is crowded
Ginkgo Bioworks (DNA) Q1 Revenues Beat; Guides Higher
May 16, 2022 4:02 PM EDTGinkgo Bioworks (NYSE: DNA) reported Q1 revenue $168 million versus the consensus estimate of $105.68 million.
GUIDANCE:
Ginkgo Bioworks sees FY2022 revenue of $375-390 million, versus the consensus of $333 million.
For earnings history and earnings-related data on Ginkgo Bioworks (DNA) click here.
... More